|
|
40
|
|
|
B012T
|
|
|
3TC 10MG/ML SOLUTION (GSK/COL) LAMIVUDINE
|
|
|
LAMIVUDINE
|
|
|
3TC
|
|
|
240ML
|
|
|
BL
|
|
|
59.88
|
|
|
0.25
|
|
|
10MG/ML
|
|
|
SOLUTION
|
|
|
0
|
|
|
ML
|
|
|
GSK
|
|
|
GLAXOSMITHKLINE
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
08180820
|
|
|
NRTI
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
ANTI-INFECTIVE AGENTS
|
|
|
|